Cargando…
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: Implications for the clinical management of LQT3 patients()
BACKGROUND: The efficacy of beta-blockers for treatment of patients with long QT syndrome type 3 (LQT3) has been repeatedly questioned, and it has been suggested that they might be detrimental for this genetic subgroup of patients with long QT syndrome (LQTS). The disquieting consequence has been th...
Autores principales: | Calvillo, Laura, Spazzolini, Carla, Vullo, Eleonora, Insolia, Roberto, Crotti, Lia, Schwartz, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882517/ https://www.ncbi.nlm.nih.gov/pubmed/24135497 http://dx.doi.org/10.1016/j.hrthm.2013.10.029 |
Ejemplares similares
-
Transgenic LQT2, LQT5, and LQT2‐5 rabbit models with decreased repolarisation reserve for prediction of drug‐induced ventricular arrhythmias
por: Hornyik, Tibor, et al.
Publicado: (2020) -
Relationship between KCNQ1 (LQT1) and KCNH2 (LQT2) gene mutations and sudden death during illegal drug use
por: Nagasawa, Sayaka, et al.
Publicado: (2018) -
Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review
por: Bagkaki, Alena, et al.
Publicado: (2021) -
Linkage Evidence for a Two-Locus Inheritance of LQT-Associated Seizures in a Multigenerational LQT Family With a Novel KCNQ1 Loss-of-Function Mutation
por: Prüss, Harald, et al.
Publicado: (2019) -
Differential diagnosis between LQT1 and LQT2 by QT/RR relationships using 24‐hour Holter monitoring: A multicenter cross‐sectional study
por: Yodogawa, Kenji, et al.
Publicado: (2021)